O6 - Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study
| Autor: | Antonelli, L., Ardizzone, D., Ravi, P., Sweeney, C., Bagrodia, A., Mego, M., Douglawi, A., Campanelli Palmer, T., Nazzani, S., Giannatempo, P., Franza, A., Paffenholz, P., Saoud, R., Eggener, S., Ho, M., Oswald, N., Olson, K., Tryakin, A., Naoun, N., Javaud, C., Fizazi, K., Cary, C., Fankhauser, C.D. |
|---|---|
| Zdroj: | In European Urology Open Science November 2022 45 Supplement 2:S53-S53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|